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Local and systemic innate immune response
to secondary human peritonitis
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Abstract
Introduction: Our aim was to describe inflammatory cytokines response in the peritoneum and plasma of patients
with peritonitis. We also tested the hypothesis that scenarios associated with worse outcome would result in
different cytokine release patterns. Therefore, we compared cytokine responses according to the occurrence of
septic shock, mortality, type of peritonitis and peritoneal microbiology.
Methods: Peritoneal and plasma cytokines (interleukin (IL) 1, tumor necrosis factor a (TNFa), IL-6, IL-10, and
interferon g (IFNg)) were measured in 66 patients with secondary peritonitis.
Results: The concentration ratio between peritoneal fluid and plasma cytokines varied from 5 (2 to 21) (IFNg) to
1310 (145 to 3888) (IL-1). There was no correlation between plasma and peritoneal fluid concentration of any
cytokine. In the plasma, TNFa, IL-6, IFNg and IL-10 were higher in patients with shock versus no shock and in
nonsurvivors versus survivors (P ≤0.03). There was no differential plasma release for any cytokine between
community-acquired and postoperative peritonitis. The presence of anaerobes or Enterococcus species in peritoneal
fluid was associated with higher plasma TNFa: 50 (37 to 106) versus 38 (29 to 66) and 45 (36 to 87) versus 39 (27 to
67) pg/ml, respectively (P = 0.02). In the peritoneal compartment, occurrence of shock did not result in any
difference in peritoneal cytokines. Peritoneal IL-10 was higher in patients who survived (1505 (450 to 3130) versus
102 (9 to 710) pg/ml; P = 0.04). The presence of anaerobes and Enterococcus species was associated with higher
peritoneal IFNg: 2 (1 to 6) versus 10 (5 to 28) and 7 (2 to 39) versus 2 (1 to 6), P = 0.01 and 0.05, respectively).
Conclusions: Peritonitis triggers an acute systemic and peritoneal innate immune response with a simultaneous
release of pro and anti-inflammatory cytokines. Higher levels of all cytokines were observed in the plasma of
patients with the most severe conditions (shock, non-survivors), but this difference was not reflected in their
peritoneal fluid. There was always a large gradient in cytokine concentration between peritoneal and plasma
compartments highlighting the importance of compartmentalization of innate immune response in peritonitis.
Introduction
Secondary peritonitis is a severe compartmentalized
infectious insult characterized by a rapid response of
innate immunity leading to a major inflammatory pro-
cess. The initial response is usually followed by a post-
injury depression of innate immunity in various types of
sepsis [1-4]. However, there is a paucity of data regard-
ing systemic and local innate immune responses during
peritonitis in humans and on their relation to prognosis
[5-8]. The outcome of secondary peritonitis has been
shown to be influenced by several clinical and bacterio-
logical features of the disease. We recently reported that
two or more micro-organisms in peritoneal fluid culture,
intra-peritoneal anaerobes, yeasts, or Enterococcus spe-
cies were associated with worse prognosis. Other groups
have suggested that postoperative peritonitis was also
associated with worse outcome [9-11], a finding that our
own observations did not corroborate [12]. Whether or
not these features are associated with differential
immune responses is unknown. Therefore, the aims of
this study were: 1) to characterize the inflammatory
mediator response (pro-inflammatory: IL-1, TNFa, IL-6,
IFNg ; and anti-inflammatory: IL-10) in the peritoneal
and blood compartments of patients with secondary
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peritonitis; 2) to evaluate the potential differences in
mediator profiles between shocked and non-shocked
patients, survivors and non survivors and according to
the type of peritonitis (community-acquired or post-
operative); and 3) to look at the potential impact of
peritoneal microbiological findings on mediator release.
Materials and methods
Over a period of two years, all patients with secondary
peritonitis admitted in our unit (surgical intensive care
unit, Lariboisière University Hospital) were prospectively
screened for peritoneal and plasma cytokine measure-
ments. The study was approved by our Institutional
Review Board (N° IRB00006477, Comité d’Ethique de la
Recherche Biomédicale du GHU Nord).
Plasma cytokine measurements were performed on
leftovers of blood from routine daily samples and
patients were informed during follow-up, but the need
for written informed consent was waived. This cohort
was a subgroup of a larger cohort of secondary peritoni-
tis, which was previously reported [12]. Patients were
included if they were older than 18 years and if the
diagnosis of secondary generalized peritonitis (commu-
nity-acquired and postoperative peritoneal infection)
was confirmed surgically. They were not included if they
had secondary peritonitis as a result of penetrating
trauma, tertiary peritonitis defined as recurrent post-
operative peritonitis, primary peritonitis (medical cause
of intra-abdominal infection that did not require sur-
gery) or if they received steroids as part of their
treatment.
Diagnosis and surgical management of generalized
peritonitis
By definition, all cases required laparotomy for abdom-
inal sepsis. After incision and visual confirmation of
intra-abdominal infection involving the whole peritoneal
cavity, peritoneal fluid was sampled for microbiology
and cytokine measurements. Abundant peritoneal lavage
was then performed using sterile saline solution. None
of our patients underwent open-wound management
and the abdomen was not irrigated after surgery.
Ostomies were systematically preferred to primary ana-
stomosis. We did not perform planned re-laparotomy
and patients were re-operated on-demand exclusively.
Septic shock definition
Septic shock was defined according to the criteria of the
Critical Care Medicine Consensus Conference as: (1)
systemic inflammatory response as defined by two or
more of the following: temperature higher than 38.5°C
or lower than 35°C, heart rate higher than 90/minute,
respiratory rate higher than 20/minute or PaCO2 less
than 32 mmHg or need for mechanical ventilation,
white blood cell count higher than 12.0 × 109/L or less
than 4.0 × 109/L or containing more than 10% imma-
ture forms; (2) evidence of a nidus of infection; and (3)
systolic blood pressure less than 90 mmHg (for at least
one hour) despite adequate fluid replacement and infu-
sion of vasopressor associated with at least two signs of
perfusion abnormality (lactic acidosis, oliguria, abrupt
alteration in mental status). Particular attention was
paid to microbiological findings in the peritoneal fluid
that were associated with worse outcome according to
our previous study (that is, higher incidence of septic
shock and/or death): the presence of polymicrobial cul-
tures (that is, ≥2 micro-organisms, bacteria or fungi),
anaerobes, Enterococcus species, and yeasts [12]. We
also evaluated the impact of ‘microbial synergy’ (that is,
association of different bacterial strains) on cytokine
plasma levels [13,14].
Cytokines measurements
Peritoneal fluid was harvested for microbiological cul-
ture and cytokine measurement immediately after open-
ing the peritoneal cavity. Plasma cytokines were
measured daily during the first three postoperative days
(D1, D2, D3). In patients presenting septic shock, the
first plasma samples were always obtained within 24
hours after the onset of septic shock. To evaluate the
balance between pro- and anti-inflammatory mediators,
four pro-inflammatory cytokines (IL-1, TNFa, IL-6 and
IFNg) as well as one anti-inflammatory cytokine (IL-10)
were measured using ELISA kits (R & D Systems Eur-
ope, Lille, France) in plasma and peritoneal fluid.
Antimicrobial therapy
Patients received antibiotics prior to anesthesia induc-
tion according to our institutional protocols. For com-
munity-acquired peritonitis, we used amoxicillin-
clavulanic acid (2 g to 200 mg) associated with gentamy-
cin (3 mg/kg) at the time of induction of anesthesia, fol-
lowed by amoxicillin-clavulanic acid (1 g to 200 mg
every six hours) and gentamycin (3 mg/kg daily) for five
days. For postoperative peritonitis, we used piperacillin-
tazobactam (4 g) with gentamycin 3 mg/kg at induction
and piperacillin-tazobactam (4 g every six hours) asso-
ciated with gentamycin (3 mg/kg daily) for five days. If a
patient was allergic, we used gentamycin (3 mg/kg/day)
associated with ornidazole (1 g) for five days. Antibiotic
therapy was then adjusted to germ sensitivity, as soon as
available.
Data collection
We collected demographic and clinical data including
age, gender, Simplified Acute Physiologic Score II (SAPS
II), ICU length of stay, occurrence of septic shock, ICU
mortality and origin of peritonitis. Microbiological and
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mycological results of all cultures (peritoneal fluid col-
lected during surgery and blood samples obtained within
the first 24 hours) were recorded.
Statistical analysis
Results are expressed as median with IQR for continuous
variables and as count and percentage for categorical
variables. Plasma cytokine profiles during the first three
days were analyzed using Friedman repeated-measures
analysis of variance on ranks. Differences in cytokine pro-
files according to the presence or absence of shock, ICU
death or nosocomial infection were tested using two-way
analysis of variance on the log-transformed values of
cytokine serum concentrations. The Mann-Whitney rank
sum test was used to compare values at Day 1 between
subgroups (community versus postoperative, mono- ver-
sus poly-microbial peritonitis) and according to the type
of bacteria in the peritoneal fluid culture (anaerobes,
Enterococcus species, yeasts). All analyses were performed
using R 2.10.1 statistical software (The R Foundation for
Statistical Computing, Vienna, Austria) and StatView
(SAS Institute Inc, San Francisco, CA, USA).
Results
Sixty-six patients with secondary peritonitis were studied
prospectively. Patient characteristics are presented in
Table 1. Twenty three patients (34%) had septic shock
and eight of them died while in ICU (ICU mortality:
34%). Laparotomy was always performed within 24 hrs
of septic shock onset. The incidence of shock did not
reach a difference between community-acquired and
post-operative peritonitis (24% versus 48%, respectively,
P = 0.08). The origin of peritonitis was colon (n = 20),
gastro-duodenal (n = 13), post-duodenal small bowel (n
= 18), biliary tract (n = 3), appendix (n = 10) and others
(n = 2). The proportion of patients with polymicrobial
cultures (≥2 germs) was 51% (n = 34 patients): anae-
robes, 18% (n = 12), Enterococcus species, 20% (n = 13),
and yeasts, 14% (n = 9).
Plasma and peritoneal fluid IL-1, TNFa, IL-6, IFNg
and IL-10 at day one (day of surgical procedure) and
the ratio of peritoneal to plasma concentrations are pre-
sented in Table 2. Concentrations of cytokines were
always higher in peritoneum than in plasma, with great
variability of the peritoneal fluid/plasma ratio among
cytokines (from 5 for IFNg to more than 1,300 for IL-1).
There was no correlation between plasma and peritoneal
fluid concentration of any cytokine.
In the plasma compartment, the IL-6 profile over the
first three days differed between shock and no-shock
patients (P < 0.03), whereas profiles of TNFa, IFNg and
IL-10 did not differ significantly (that is, no significant
interaction) but inter-group and overtime differences
were noted between the two groups (Figure 1). Compar-
ing survivors versus non-survivors, TNFa plasma profiles
had a significant interaction (P < 0.008) while IL-6, IFNg
and IL-10 exhibited only intergroup and overtime differ-
ences (Figure 2). Regardless of the clinical situation,
plasma IL-1 did not differ among groups: shock versus
no shock (5 (5 to 8) versus 5 (5 to 8) pg/ml, P = 0.54) and
survival versus non survival (5 (5 to 8) versus 5 (5 to 6)
pg/ml, P = 0.73). There was no difference in plasma cyto-
kine concentrations between community-acquired and
post-operative peritonitis. Plasma cytokine levels accord-
ing to bacteriological findings (mono- versus poly-micro-
bial cultures of peritoneal fluid, presence or not of
anaerobes, Enterococcus, or yeast) are presented in Table
3. Plasma TNFa was significantly higher in the case of
polymicrobial culture or when anaerobes or Enterococcus
were present in the peritoneal fluid. Plasma IL-10 was
significantly higher in the case of polymicrobial culture
or when anaerobes were present in the peritoneal fluid.
We did not find any difference in peritoneal cytokines
with regard to the occurrence of shock. Only peritoneal
levels of IL-10 were higher in survivors versus non-sur-
vivors (1,505 pg/ml (450 to 3,130) versus 102 pg/ml (9
to 710), respectively, P = 0.04). Table 4 shows peritoneal
cytokine levels in relation to bacteriological findings.
Anaerobes and Enterococcus species were associated
with higher IFNg in peritoneal fluid. The presence of
yeast did not result in higher plasma or peritoneal
Table 1 Patient characteristics
Patients Number = 66
Age (years) 59 (48 to 72)
Sex ratio F/M 36 (55%)/30 (45%)
Septic shock 23 (35%)
Average length of ICU stay (days) 20 ± 24 (1 to 109)
Community-acquired/post-operative 37 (56%)/29 (44%)
SAPS II 32.5 (18 to 48)
Overall ICU mortality 8 (12%)
Mortality among septic shock 8 (34%)
Nosocomial infections 31 (47%)
Results are expressed as mean ± SD and/or (range) or as number (%). F,
female; M, male; SAPS II, Simplified Acute Physiologic Score II.
Table 2 Plasma and peritoneal fluid cytokines and
peritoneal fluid/plasma ratio at Day 1 of peritonitis
Plasma
(pg/ml)
Peritoneal fluid
(pg/ml)
Peritoneal/plasma
ratio
IL-1 5 (5 to 8) 7,190 (1,180 to 22,670) 1,310 (145 to 3,888)
TNFa 40 (29 to 69) 262 (90 to 882) 158 (8 to 454)
IL-6 907 (289 to
2,389)
164,352 (22,859 to
328,410)
25 (3 to 75)
IFN g 1 (1 to 3) 3 (1 to 9) 5 (2 to 21)
IL-10 43 (21 to 136) 1,135 (260 to 2,945) 25 (4 to 75)
Values are expressed as median (25th to 75th percentiles).
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cytokine levels, but only a few patients from our cohort
(n = 9) had yeast in their peritoneal fluid.
Discussion
In this cohort of 66 patients with secondary generalized
peritonitis, we observed a large gradient between
peritoneal fluid and plasma concentrations of cytokines,
with no correlation between peritoneal and plasma
levels. Plasma TNFa, IL-6, IFNg and IL-10 were higher
in patients with shock and in non survivors and
decreased over the first three postoperative days in a
parallel manner. Plasma cytokines did not differ between
Figure 1 Time course of plasma cytokines in patients with septic shock and no septic shock.
Figure 2 Time course of plasma cytokines in non-survivors and survivors.
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community-acquired and postoperative peritonitis. The
presence of peritoneal anaerobes or Enterococcus species
was associated with a higher plasma level of TNFa. IL-
10 plasma levels were also higher when anaerobes or
polymicrobial positive culture were found. In the perito-
neal compartment, there was no difference in cytokine
concentration between shock and no shock patients, but
there was a greater IL-10 concentration in survivors.
The presence of anaerobes and Enterococcus species was
associated with higher peritoneal IFNg.
There are very limited data on innate immune
response assessed by plasma and peritoneal inflamma-
tory mediators in patients with secondary peritonitis. To
our knowledge, only one study addressed this issue and
reported a large concentration gradient for TNFa and
IL-6 between peritoneal fluid and plasma in a small
group (n = 17) of patients with peritonitis [6]. Our
results confirm that IL-1, TNFa, IL-6, IL-10 and IFNg
are present at high concentrations in the peritoneal fluid
of patients with peritonitis. This observation fits well
with the concept of the ‘tip of the iceberg’ which sug-
gests that plasma levels increase only after saturation of
tissues within the abdominal compartment [15,16].
However, a direct intravascular stimulation of cytokine
release by monocytes cannot be ruled out in some
patients, especially when bacteremia occurred, since this
condition is associated with higher plasma cytokines
[17]. In this cohort, the proportion of positive blood cul-
tures within the first 48 hours of peritonitis was 11/66
(16%).
We also observed that plasma levels of pro- and anti-
inflammatory mediators were higher in patients with
shock and in non-survivors, a finding that has been
reported by several authors [1,6-8,18,19]. The fact that
pro- and anti-inflammatory mediators are released
simultaneously during the early phase of peritoneal sep-
sis confirms what was recently noted in animal models
of sepsis [20] and septic patients [4,21,22]. The only
data available regarding IFNg and outcome during
abdominal infection come from experimental studies
and the results are conflicting. According to some
authors, low plasma IFNg is associated with increased
mortality [23,24] while others reported that prophylactic
inhibition of IFNg improves survival [25,26]. Our values
for plasma and peritoneal IFNg measurements represent
the first set of data in humans with GP. The plasma
concentration of IFNg was very low compared to other
cytokines, in accordance with what has been observed in
experimental models of peritonitis [4].
Similarly, no human data were available on IL-10 during
peritonitis. Experimental studies suggest that intra-perito-
neal or subcutaneous IL-10 injections reduce mortality
Table 3 Plasma cytokines (pg/ml) at Day 1 according to peritoneal fluid culture
Monomicrobial (number = 34) Polymicrobial (number = 32) P value
IL-1 5 (5 to 8) 5 (5 to 7) 0.19
TNFa 36 (26 to 52) 45 (31 to 100) 0.02
IL-6 630 (243 to 1,360) 1,500 (510 to 2,828) 0.51
IL-10 27 (5 to 67) 50 (30 to 210) 0.03
IFNg 1 (1 to 2) 1 (1 to 3) 0.49
No anaerobes (number = 44) Anaerobes (number = 12)
IL-1 5 (5 to 8) 5 (5 to 8) 0.93
TNFa 38 (29 to 66) 50 (37 to 106) 0.017
IL-6 876 (300 to 1,846) 2,755 (456 to 4,550) 0.21
IL-10 40 (17 to 90) 197 (27 to 715) 0.0005
IFNg 1 (1 to 2) 1 (1 to 13) 0.12
No Enterococcus sp. (number = 43) Enterococcus sp. (number = 13)
IL-1 5 (5 to 7) 5 (5 to 9) 0.79
TNFa 39 (27 to 67) 45 (36 to 87) 0.02
IL-6 880 (283 to 2,618) 1,500 (630 to 2,325) 0.71
IL-10 40 (20 to 114) 50 (30 to 154) 0.17
IFNg 1 (1 to 3) 1 (1 to 5) 0.32
No yeast (number = 57) Yeast (number = 9)
IL-1 5 (5 to 8) 5 (5 to 5) 0.39
TNFa 39 (29 to 63) 52 (40 to 88) 0.54
IL-6 855 (283 to 2,282) 1,360 (1,085 to 2,580) 0.65
IL-10 40 (20 to 129) 50 (39 to 119) 0.96
IFNg 1 (1 to 2) 2 (1 to 3) 0.62
Results are presented as median (25th to 75th percentiles). See text for details.
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[27], which fits well with our observation that the intra-
peritoneal IL-10 concentration was greater in survivors.
Since IL-10 is considered an anti-inflammatory mediator,
our findings corroborate the fact that both pro- and anti-
inflammatory mediators are produced simultaneously in
the peritoneum of patients with peritonitis [28].
In a previous study, we found that polymicrobial cul-
tures or anaerobes in the peritoneal fluid are associated
with more frequent septic shock [12]. The role of the
infecting pathogen on the innate immune response of
patients with peritonitis has been poorly investigated.
Controversy exists regarding a specific role of some
pathogens on the pattern of the immune response.
Some authors support the concept of a ‘generic septic
response’ in which an identical immune response is trig-
gered by any type of bacteria [29,30]. This theory has
been contradicted by others who suggested that different
types of germs may elicit various immune responses,
despite a common pathway of activation. For example,
distinct host responses to Streptococcus pneumoniae or
Pseudomonas aeruginosa have been reported in experi-
mental models of pneumonia [31]. In humans with sep-
sis of various origins, Gogos et al. recently observed that
HLA-DR expression and the apoptosis rate of CD-4 and
CD-8 within 24 hours of sepsis onset varied according
to the underlying pathogen [32]. In rats with peritonitis,
Montravers et al. showed that adjunction of Enterococ-
cus faecalis is associated with increased mortality as well
as higher levels of TNFa and IL-6 in peritoneal fluid
[33,34]. In the present study, we observed that patients
in whom anaerobes or Enterococcus species were iso-
lated from peritoneal fluid cultures released more TNFa
in their plasma than those who were infected with other
strains. One of the limitations of our study is that the
number of patients with specific characteristics or bac-
teriological findings in each subgroup is rather small,
preventing any definitive conclusion to be drawn from
these results. In addition, small differences must be con-
sidered cautiously as multiple comparisons were per-
formed to compare various subgroups. However, some
of the observations we made are consistent with pre-
vious experimental findings and, therefore, provide the
first human data to support laboratory hypotheses.
Conclusions
Secondary peritonitis is responsible for an acute local
and systemic innate immune response involving a simul-
taneous release of both pro- and anti-inflammatory
mediators. The most severely affected patients had
higher plasma levels of all cytokines but this difference
was not observed with peritoneal fluid cytokines. A
large gradient in cytokine concentration was noted
Table 4 Peritoneal fluid cytokines (pg/ml) at Day 1, according to peritoneal fluid culture
Monomicrobial (number = 34) Polymicrobial (number = 32) P value
IL-1 8,194 (3,115 to 31,440) 4,400 (509 to 16,730) 0.09
TNFa 290 (89 to 1,185) 260 (93 to 695) 0.42
IL-6 72,390 (13,760 to 201,600) 236,800 (86,670 to 383,700) 0.02
IL-10 550 (243 to 4,246) 1,505 (320 to 2,610) 0.78
IFNg 3 (1 to 23) 2 (1 to 7) 0.23
No anaerobes (number = 44) Anaerobes (n = 12)
IL-1 4,682 (1,000 to 19,220) 26,000 (7,282 to 54,890) 0.04
TNFa 252 (95 to 851) 805 (88 to 1,009) 0.54
IL-6 164,400 (25,380 to 328,400) 156,800 (1,536 to 270,300) 0.44
IL-10 1,252 (386 to 2,785) 370 (167 to 4,380) 0.96
IFNg 2 (1 to 6) 10 (5 to 28) 0.01
No Enterococcus sp. (number = 43) Enterococcus sp. (number = 13)
IL-1 4,850 (1,000 to 22,580) 8,528 (1,850 to 38,880) 0.33
TNFa 265 (96 to 848) 185 (87 to 1,592) 0.89
IL-6 195,600 (25,460 to 342,800) 51,400 (12,800 to 190,000) 0.12
IL-10 1,755 (403 to 3,679) 435 (167 to 480) 0.01
IFNg 2 (1 to 6) 7 (2 to 39) 0.05
No yeast (number = 57) Yeast (number = 9)
IL-1 7,859 (1,417 to 27,090) 3,010 (840 to 4,693) 0.25
TNFa 285 (90 to 953) 120 (96 to 530) 0.37
IL-6 143,300 (20,630 to 348,300) 196,800 (98,600 to 215,100) 0.88
IL-10 1,252 (358 to 2,902) 465 (40 to 2,292) 0.34
IFNg 3 (2 to 9) 2 (1 to 4) 0.16
Results are presented as median (25th to 75th percentiles). See text for details
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between the peritoneal cavity and plasma, highlighting
the importance of compartmentalization of innate
immune response during peritonitis.
Key messages
• Compartmentalization of innate immune response
during peritonitis is reflected by a large gradient in
cytokine concentration between peritoneum and
plasma.
• Higher plasma levels of pro and anti-inflammatory
cytokines are associated with shock and mortality.
• Innate immune response was not different between
patients with post-operative and community-
acquired peritonitis.
• The infecting pathogen might influence host
immune response.
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